Note: Bio-Med Diagnostics's revenues are gauged from an analysis of company filings.
Bio-Med Diagnostics's Income Statement (based on Industry Averages)
Bio-Med Diagnostics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Bio-Med Diagnostics is developing and marketing.
Bio-Med Diagnostics doesn't have any recent trademark applications, indicating Bio-Med Diagnostics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
INPOUCH Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes
10/27/2016
INTRAY Diagnostic preparations for medical or veterinary purposes
10/27/2016
INPOUCH TG Diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in testing for the presence of Trichomonas Gallinae
05/27/2015
See all trademarks and details in the Full Report.
Market Share of Bio-Med Diagnostics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Bio-Med Diagnostics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Bio-Med Diagnostics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Bio-Med Diagnostics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.